Recent Updates

Share
Twitter Facebook LinkedIn Forward
Published: 
Aug 1, 2018

Therapeutic Apheresis

Chapter 14

Apheresis involves the removal of whole blood from an individual and its separation into components. A specified component is retained and the remainder is returned to the individual. Therapeutic apheresis is used to treat patients with a variety of disorders and has become a relatively common treatment modality. The rationale and techniques for therapeutic apheresis, as well as the care of the apheresis patient, will be discussed in this chapter.

Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Jul 20, 2018

Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia

Chapter 12

This chapter reviews the testing and treatments that are relevant for mothers and their fetuses/infants during pregnancy and postnatally to reduce the risks of hemolytic disease of the fetus and newborn (HDFN) and of immune thrombocytopenias.

Transfusion
Share
Twitter Facebook LinkedIn Forward
Published: 
Aug 16, 2018

Platelet Transfusion, Alloimmunization and Management of Platelet Refractoriness

Chapter 18

Platelets are the smallest of the blood cells, with a diameter of two to three microns and no nucleus. Their main function is to mediate primary hemostasis, though they are involved in a number of other processes including primary immunity, tumour progression and inflammation. 

Transfusion
more

Upcoming Events

Topic Teaching: Clinical outcomes among low-titer group O whole blood recipients compared to recipients of conventional components in civilian trauma resuscitation

Share
Twitter Facebook LinkedIn Forward
When
December 18, 2018 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Presented by:

Dr. Pierre-Aurele Morin
Transfusion Medicine Physician Trainee
McMaster University

Objectives:

1.  Discuss the characteristics of whole blood and potential advantages.
2.  Review available data on whole blood transfusion in trauma patients.
3.  Evaluate a study on the clinical impact of whole blood transfusion.

Transfusion

Topic Teaching: Donor & Donation Considerations: Testosterone Use in Donors, Transgender Donor Relations

Share
Twitter Facebook LinkedIn Forward
When
January 8, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Speakers:

Dr. Ian Chin-Yee
Chief/Chair of the Division of Hematology, Department of Medicine, University of Western Ontario
Consultant, Department of Medicine, Long Health Sciences Centre
Professor of Medicine, University of Western Ontario
Honourary Consultant, Hematology/Oncology, Long Regional Cancer Centre
Associate Medical Director/Consultant, Canadian Blood Services
Medical Director, Adults, Bleeding Disorders Program, LHSC

Terrie Foster, RN
Canadian Blood Services

 

More details to follow.

 

Transfusion

Topic Teaching: Red Cell Genotyping

Share
Twitter Facebook LinkedIn Forward
When
January 15, 2019 | 12:00PM to 1:00PM
Where

Toronto/Webinar

Speaker:

Dr. Philip Berardi, MD, PhD, FRCPC
Medical Consultant, Canadian Blood Services
Assistant Professor, University of Ottawa, Department of Pathology and Laboratory Medicine, Faculty of Medicine
Staff Hematopathologist, The Ottawa Hospital
Clinical Investigator, Cancer Therapeutics Program, The Ottawa Hospital Research Institute

 

More details to follow.

 

Transfusion
more

Blog

Modified on: 
Dec 12, 2018
Share
Twitter Facebook LinkedIn Forward

12th Earl W. Davie Symposium: a focus on the next-generation of blood researchers

In November, the University of British Columbia Centre for Blood Research (CBR) hosted its 12th annual Earl W. Davie Symposium in Vancouver, BC. During the event, researchers, students, clinicians and patients discussed successes and ongoing challenges in hematology, from understanding basic mechanisms of clotting to improving patient care.

Modified on: 
Dec 2, 2018
Share
Twitter Facebook LinkedIn Forward

Funded research providing evidence needed to evolve eligibility criteria for men who have sex with men

Canadian Blood Services has recently made progress on several fronts that may further evolve the eligibility criteria for men who have sex with men. This includes supporting more research projects as part of the MSM Research Grant Program and working to reduce the waiting period from one year to three months based on the latest evidence.

Modified on: 
Nov 26, 2018
Share
Twitter Facebook LinkedIn Forward

Raising awareness for living organ donation

This #givingtuesday — November 27, 2018 — organizations across the country are raising awareness about living donation. 

Did you know that more than 3,000 Canadians are on a waiting list for kidney transplantation?

more